Ranbaxy
-
Franchise India Bureau Oct 13 2017 - 1 min readMajor drug company Sun Pharmaceutical said it will increase share in its peripheral Ranbaxy Malaysia SDN BHD to 79.5 through purchasing of share. Sun Pharma said in a filling to the BSE “One of the wholly owned subsidiaries of the company has agreed to increase its shareholding in Ranbaxy Malaysia Sdn Bhd by 8.3 per ...
-
Agencies Sep 29 2017 - 2 min readApproving the Scheme of Arrangement involving merger of Ranbaxy Laboratories with Sun Pharmaceutical Industries, the High Court of Punjab and Haryana has orally approved the merger of two biggies. According to Sun Pharmaceutical, a certified true copy of the court order is awaited. Reportedly, the US Federal Trade Commission (FTC) recently approved ...
-
Agencies Sep 29 2017 - 2 min readSoon after Sun Pharma received nod from Apex Court of Punjab and Haryana to acquire Ranbaxy, scion of former brand Aalok Sanghvi is expected to head the emerging market units, as Abhay Gandhi, Business Head of the brand, will take charge of domestic business. Taking forward its acquisition of Ranbaxy Laboratories, Sun Pharma has ...
-
WI Bureau Sep 29 2017 - 2 min readSun Pharmaceutical announced that Ranbaxy will be delisted from the Indian Stock Exchange as their $4 billion merger is completing. Reportedly, while filing to the BSE, Sun Pharma said, “Following the closure of this transaction, Ranbaxy will be delisted from the Indian Stock Exchanges. Ranbaxy shareholders will receive 0.8 share of Sun Pharma for ...
-
Agencies Sep 29 2017 - 2 min readEmboldened by its takeover of domestic rival Ranbaxy Laboratories, India's leading Pharma company Sun Pharmaceuticals Industries Ltd is willing to spend as much as $7 billionon further acquisitions The biggest deal till date at $3.2 billion, the Ranbaxy deal of Sun Pharma has given it sufficient scale in generics and emerging markets to think ...